Substance / Medication

Polyestradiol phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

78 trials linked to this intervention

78
Total Trials
14
Recruiting
23
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Women's experiences of premature ovarian insufficiency: a thematic synthesis.
Hammond Jennifer, Marczak Magda · Psychol Health · 2025
PMID: 36971566Meta-Analysis
Intraovarian injection of autologous platelet-rich-plasma: myth or reality?
Loverro Giuseppe, DI Naro Edoardo, Loverro Matteo et al. · Minerva Obstet Gynecol · 2025
PMID: 39388219Meta-Analysis
Efficacy of Gonadotropin Treatment for Induction of Spermatogenesis in Men With Pathologic Gonadotropin Deficiency: A Meta-Analysis.
Muir Christopher A, Zhang Ting, Jayadev Veena et al. · Clin Endocrinol (Oxf) · 2025
PMID: 39445789Meta-Analysis
The effectiveness of yoga on menopausal symptoms: A systematic review and meta-analysis of randomized controlled trials.
Wang Hongjuan, Liu Yaqian, Kwok Jojo Yan Yan et al. · Int J Nurs Stud · 2025
PMID: 39467491Meta-Analysis
Gonadotropin Therapy for Mini-Puberty Induction in Male Infants With Hypogonadotropic Hypogonadism.
Rhys-Evans Sophie, d'Aniello Francesco, Alexander Emma C et al. · J Clin Endocrinol Metab · 2025
PMID: 39673783Meta-AnalysisFull text (PMC)
Fezolinetant and Elinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis.
Menegaz de Almeida Artur, Oliveira Paloma, Lopes Lucca et al. · Obstet Gynecol · 2025
PMID: 39746208Meta-Analysis
Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate.
Mikkola Arto, Aro Jussi, Rannikko Sakari et al. · Scand J Urol Nephrol · 2005
PMID: 16261661Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Polyestradiol phosphate (substance)
SNOMED CT
126084009
UMLS CUI
C0071554

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

7
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
78
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Polyestradiol phosphate — Conditions, Biomarkers & Specialists | Healos | Ltrl